MedTrace Logo

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

NCT06164834 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-12-11

No results posted yet for this study

Summary

This study aims to evaluate the effects of tegoprazan or esomeprazole administered in combination with clopidogrel on the pharmacodynamics/Pharmacokinetics of clopidogrel in healthy adults

Conditions

  • Healthy

Interventions

DRUG

Clopidogrel 75 mg

Clopidogrel 75 mg tablet

DRUG

Tegoprazan 25 mg

Tegoprazan 25 mg tablet

DRUG

Esomeprazole 20mg

Esomeprazole 20 mg tablet

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Seung Hwan Lee · Seoul National University Hospital, Dept. of Clinical Pharmacology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-05
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06164834 on ClinicalTrials.gov